TITLE

Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome

AUTHOR(S)
Brooke, Benjamin S.; Habashi, Jennifer P.; Judge, Daniel P.; Patel, Nishant; Loeys, Bart; Dietz, Harry C.
PUB. DATE
June 2008
SOURCE
New England Journal of Medicine;6/26/2008, Vol. 358 Issue 26, p2787
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Progressive enlargement of the aortic root, leading to dissection, is the main cause of premature death in patients with Marfan's syndrome. Recent data from mouse models of Marfan's syndrome suggest that aortic-root enlargement is caused by excessive signaling by transforming growth factor � (TGF-�) that can be mitigated by treatment with TGF-� antagonists, including angiotensin II�receptor blockers (ARBs). We evaluated the clinical response to ARBs in pediatric patients with Marfan's syndrome who had severe aortic-root enlargement. Methods: We identified 18 pediatric patients with Marfan's syndrome who had been followed during 12 to 47 months of therapy with ARBs after other medical therapy had failed to prevent progressive aortic-root enlargement. The ARB was losartan in 17 patients and irbesartan in 1 patient. We evaluated the efficacy of ARB therapy by comparing the rates of change in aortic-root diameter before and after the initiation of treatment with ARBs. Results: The mean (�SD) rate of change in aortic-root diameter decreased significantly from 3.54�2.87 mm per year during previous medical therapy to 0.46�0.62 mm per year during ARB therapy (P<0.001). The deviation of aortic-root enlargement from normal, as expressed by the rate of change in z scores, was reduced by a mean difference of 1.47 z scores per year (95% confidence interval, 0.70 to 2.24; P<0.001) after the initiation of ARB therapy. The sinotubular junction, which is prone to dilation in Marfan's syndrome as well, also showed a reduced rate of change in diameter during ARB therapy (P<0.05), whereas the distal ascending aorta, which does not normally become dilated in Marfan's syndrome, was not affected by ARB therapy. Conclusions: In a small cohort study, the use of ARB therapy in patients with Marfan's syndrome significantly slowed the rate of progressive aortic-root dilation. These findings require confirmation in a randomized trial. N Engl J Med 2008;358:2787-95.
ACCESSION #
32765958

 

Related Articles

  • Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. Colman, Ian; Friedman, Benjamin W.; Brown, Michael D.; Innes, Grant D.; Grafstein, Eric; Roberts, Ted E.; Rowe, Brian H. // BMJ: British Medical Journal (International Edition);6/14/2008, Vol. 336 Issue 7657, p1359 

    Objective To examine the effectiveness of parenteral corticosteroids for the relief of acute severe migraine headache and prevention of recurrent headaches. Design Meta-analysis. Data sources Electronic databases (Cochrane Central Register of Controlled Trials, Medline, Embase, LILACS, and...

  • Novel Diabetes Treatments: New and Future Developments. Buckley, Rita // MD Conference Express;Aug2011, p22 

    The article reports on research which was conducted by Ernest M. Wright of the David Geffen School of Medicine at the University of California in Los Angeles, California on sodium glucose cotransporter 2 (SGLT2) inhibitors which are used in the treatment of hyperglycemia in diabetes. Research...

  • Multicenter International Lymphangioleiomyomatosis Efficacy and Safety of Sirolimus Trial.  // MD Conference Express;Aug2011, p10 

    The article reports on research which was conducted by physician Francis X. McCormack of the University of Cincinnati in Cincinnati, Ohio to investigate the safety and efficacy of using the drug sirolimus to improving lung function in lymphangioleiomyomatosis. McCormack's research found that...

  • Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. De Backer, T.; Stichele, R. Vander; Lehert, P.; Van Bortel, L. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/21/2009, p703 

    The article focuses on the results of research which was conducted in an effort to determine the efficacy and safety of the oral vasoactive drug naftidrofuryl when compared with placebo in improving walking distance in patients with intermittent claudication. Researchers examined medical...

  • Evaluation of Vitreous Clearance and Potential Retinal Toxicity of Intravitreal Lornoxicam (Xefo). Diakonis, Vasilios F.; Tsourdou, Antigoni; Tzatzarakis, Manolis N.; Tsika, Chrysanthi; Charisis, Spyridon; Naoumidi, Irini; Plainis, Sotiris; Tsilimbaris, Miltiadis K. // Journal of Ocular Pharmacology & Therapeutics;Sep2013, Vol. 29 Issue 7, p627 

    Purpose: To evaluate the vitreous clearance and toxicological profile of commercially available lornoxicam (Xefo), after a single intravitreal injection in rabbits. Methods: Twenty-five male albino rabbits (10 rabbits were used for retinal toxicity evaluation, while 15 rabbits were used to...

  • The Effect of Ocular Pigmentation on Transscleral Delivery of Triamcinolone Acetonide. Du, Wennan; Sun, Shumao; Xu, Yu; Li, Jie; Zhao, Chunhui; Lan, Bifei; Chen, Hao; Cheng, Lingyun // Journal of Ocular Pharmacology & Therapeutics;Sep2013, Vol. 29 Issue 7, p633 

    Purpose: To determine the capacity and kinetics of the binding between triamcinolone acetonide (TA) and the ocular pigment for a better understanding of the transscleral delivery. Methods: In the in vitro study, natural melanin ( sepia officinalis, Sigma-Aldrich) was incubated at 37°C with...

  • Heart Benefits from Two-Drug Therapy.  // Journal of Gerontological Nursing;Feb2009, Vol. 35 Issue 2, p8 

    The article reports on the results of the Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial, which was funded by the pharmaceutical firm Novartis. The results of the trial, which involved 11,506 participants and compared...

  • Pharmaceutical treatment for cognitive deficits in Alzheimer’s disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps. Bartus, Raymond; Dean, Reginald // Psychopharmacology;Jan2009, Vol. 202 Issue 1-3, p15 

    Over 30 years ago, we began to develop a nonhuman primate model to study cognitive deficits of age-related neurodegenerative diseases and their neuroanatomical–neurochemical underpinnings for purposes of translating this work toward first pharmacotherapies. This effort produced several...

  • Long-Term Results of Reconstruction for Treatment of a Flexible Cavovarus Foot in Charcot-Marie-Tooth Disease. Ward, Christina M.; Dolan, Lori A.; Bennett, D. Lee; Morcuende, Jose A.; Cooper, Reginald R. // Journal of Bone & Joint Surgery, American Volume;Dec2008, Vol. 90-A Issue 12, p2631 

    Background: Cavovarus foot deformity is common in patients with Charcot-Marie-Tooth disease. Multiple surgical reconstructive procedures have been described, but few authors have reported long-term results. The purpose of this study was to evaluate the long-term results of an algorithmic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics